NCT05743101View on ClinicalTrials.gov

Safety and Efficacy Study of Levofloxacin Combined With Endovascular Thrombectomy for Acute Ischemic Stroke

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

July 1, 2026

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Levofloxacin

Levofloxacin is a quinolone antibiotics and newly identified neuro-protective agent.Endovascular thrombectomy is one of the treatments for acute ischemic stroke.

DRUG

Levofloxacin simulant

Levofloxacin simulant is placebo.Endovascular thrombectomy is one of the treatments for acute ischemic stroke.

All Listed Sponsors
lead

Yi Yang

OTHER

NCT05743101 - Safety and Efficacy Study of Levofloxacin Combined With Endovascular Thrombectomy for Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter